| HER2-Positive Breast Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived77 of 77show fewer |
|---|
| → investigated in trials for | Trastuzumabmonoclonal_antibody 116 trials (39 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 116 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal_antibody 52 trials (28 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 52 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 34 trials (15 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall_molecule 28 trials (14 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 27 trials (13 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall_molecule 24 trials (9 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pyrotinibsmall molecule 24 trials (15 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 22 trials (4 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tucatinibsmall_molecule 19 trials (9 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 17 trials (8 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neratinibsmall_molecule 11 trials (7 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall_molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Letrozolesmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall_molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hormone Therapy 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tamoxifensmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanidatamabmonoclonal antibody 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anastrozolesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Goserelinother 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Margetuximabmonoclonal_antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall_molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganetespibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Deruxtecanadc 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aromatase Inhibitor 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Datopotamab Deruxtecanadc 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Disitamab Vedotinadc 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall_molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Exemestanesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inavolisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lasofoxifenesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Luminespibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumab/Trastuzumab Regimen 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pexidartinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pidnarulexsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retaspimycin Hydrochloridesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rezatapoptsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taxane Compound 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tyrosine Kinase Inhibitor 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |